CHF-6523
CHF-6523 is an orally active PI3Kδ inhibitor that can be used in research related to chronic obstructive pulmonary disease (COPD) [1].
Product Specifications
CAS Number
2500579-21-3
UNSPSC
12352211
Target
PI3K
Type
Reference compound
Related Pathways
PI3K/Akt/mTOR
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/chf-6523.html
Smiles
CN(CC1)CCN1CC2=CC(C(C3=CC=CC=C34)=C([C@H](C)N5C(N=CN=C6N)=C6C(C7=CN=CC(O)=C7)=N5)OC4=O)=CC=C2
Molecular Formula
C33H32N8O3
Molecular Weight
588.66
References & Citations
[1]First-Time Drug Disclosures- 2024 EFMC-ISMC and ACS Fall
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
Phase 1
Isoform
PI3Kδ
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
LY401506 100 µg
GPR44 (PTGDR2) (NM_004778) Human Over-expression Lysate
Sign In for Pricing
View Details 
PDMH100381-01 20 µg
Recombinant Human Glypican-1/GPC1 protein (His tag)
Sign In for Pricing
View Details PDMH100381-02 100 µg
Recombinant Human Glypican-1/GPC1 protein (His tag)
Sign In for Pricing
View Details